Hypertension Registry of "Hypertension Prevention and Control Initiative in China"
NCT ID: NCT04289701
Last Updated: 2020-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200000 participants
OBSERVATIONAL
2019-10-08
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Type: A national, multicenter, observational, prospective cohort study.
Study Design: The cardinal contents of this registry study are as follows:
Introduce the Digital Information System and train in completing case report forms.
Collect sociodemographic information, lifestyle behaviors, self-reported personal medical history, BP, anthropometric measurements, medication at registration, laboratory investigations of hypertension patients managed in the "Hypertension Prevention and Control Initiative in China" project. Build a baseline database of hypertension patients.
Gather the follow up information including general, clinical, therapeutic, prognostic data of all recruits at 3-month intervals over 2 years and build up the follow-up database.
Data management, quality control and statistic analysis: Digital Information Platform for data capture, document and cloud computing has been built and the investigators will manage and analyze data in align with key indicators. The investigators have invited professional statistic analysts to assist analyzing data and a third party to supervise data quality.
Ethics: The Ethics Committee of Fuwai Hospital approved this study. Informed consents before patient enrollment are required.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hypertension Cohort
Hypertension patients recruited in the "Hypertension Prevention and Control Initiative in China" project.
Health Services for Systematic Hypertension Management
The systematic hypertension management health services from the "Hypertension prevention and control initiative in China" project. Main services are as follows:
1. Healthcare provider training and patient education.
2. Standardized guideline-based hypertension diagnosis, treatment and management recommendation.
3. Patient-centered, pan-cycle continuous hypertension management via the organizing framework of NMAH and sharing digital platform.
4. Periodical Patient follow-up via blood pressure monitor-sharing system and in collaboration with other basic local public health programs.
5. Outcome and performance evaluation quarterly.
6. Incentives for healthcare organizations and primary healthcare providers, and subsidies to patients.
7. Certification for "Honorary Hypertension Centers" at county levels and establishment for hypertension clinics at primary care centers.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health Services for Systematic Hypertension Management
The systematic hypertension management health services from the "Hypertension prevention and control initiative in China" project. Main services are as follows:
1. Healthcare provider training and patient education.
2. Standardized guideline-based hypertension diagnosis, treatment and management recommendation.
3. Patient-centered, pan-cycle continuous hypertension management via the organizing framework of NMAH and sharing digital platform.
4. Periodical Patient follow-up via blood pressure monitor-sharing system and in collaboration with other basic local public health programs.
5. Outcome and performance evaluation quarterly.
6. Incentives for healthcare organizations and primary healthcare providers, and subsidies to patients.
7. Certification for "Honorary Hypertension Centers" at county levels and establishment for hypertension clinics at primary care centers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Residing in the local administrative area for at least 6 months.
3. Hypertension：defined as systolic blood pressure (SBP) ≥140 mmHg and/or /diastolic blood pressure (DBP) ≥90 mmHg and/or use of antihypertensive medication within two weeks.
4. Informed consent.
Exclusion Criteria
2. patients with severe liver or renal diseases.
3. patients with history of malignant tumor.
4. patients with mental illness that impair their consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese Academy of Medical Sciences, Fuwai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jun Cai
Director，Hypertension Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jun Cai, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Chinese Academy of Medical Sciences, Fuwai Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affliated Hospital of Anhui Medical University
Hefei, Anhui, China
Chinese Academy of Medical Sciences，Fuwai Hospital
Beijing, Beijing Municipality, China
Beijing Shunyi District Hospital
Beijing, Beijing Municipality, China
First affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
The second affiliated hospital of Baotou medical college
Baotou, Inner Mongolia, China
The Second Affilated Hospital Of Nanchang University
Nanchang, Jiangxi, China
Yinchuan First People's Hospital
Yinchuan, Ningxia, China
First Affiliated Hospital, Xian Jiaotong University
Xi’an, Shanxi, China
Teda International Cardiovascular Hospital
Tianjin, Tianjin Municipality, China
FuWai YunNan Cardiovascular Hospital
Kunming, Yunnan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-ZX20
Identifier Type: -
Identifier Source: org_study_id